TY - JOUR A1 - Hacker, Jörg A1 - Hughes, C. A1 - Hof, H. A1 - Goebel, W. T1 - Cloned hemolysin genes from Escherichia coli that cause urinary tract infection determine different levels of toxicity in mice N2 - After intraperitoneal injection of mice with Escherichia coli strains isolated from patients with urinary tract infections, the mortality due to hemolytic (Hly+) and nonhemolytic (Hiy-) isolates was 77 and 40%, respectively. Deletion of the chromosomal hemolysin (h/y) determinant in an E. co/i 06:K15:H31 urinary tract infection strain led to a significant reduction in toxicity for mice, and its reintroduction on a recombinant plasmid partially restored the original toxicity. Although introduction of the cloned plasmid pHiy152-encoded hly determinant into the Hly- E. coli 06 mutant strain increased toxicity by only a marginal degree, transformation with the cloned chromosomal hly determinants from two E. coli strains of serotypes 018ac:K5:H- and 075:K95:H? resulted in markedly greater toxicity, even exceeding that of the original Hly+ E. coli 06 wild-type strain. KW - Infektionsbiologie Y1 - 1983 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-59330 ER - TY - JOUR A1 - Hacker, Jörg A1 - Ott, M. A1 - Hof, H. T1 - Effects of low, subinhibitory concentrations of antibiotics on expression of a virulence gene cluster of pathogenic E. coli by using a wild-type gene fusion N2 - No abstract available KW - Infektionsbiologie Y1 - 1993 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-59874 ER - TY - JOUR A1 - Hacker, Jörg A1 - Hof, H. A1 - Emödy, L. A1 - Goebel, W. T1 - Influence of cloned Escherichia coli hemolysin genes, S fimbriae and serum resistance on pathogenicity in different animal models N2 - The virulence of the uropathogenic E. coli strain 536 (06: K 1 5: H31) which produces the S-fimbrial adhesin (Sfa•), is serum-resistant (Sre+) and hemolytic (Hiy+) and its derivatives were assessed in five different animal models. Cloned hemolysin (h/y) determinants from the Chromosomes of 06,018 and 075 E. colistrains and from the plasmid pHiy152 were introduced into the spontaneaus Sfa-, Sre-, Hly- mutant 536-21 and its Sfa+, Sre+, Hly- variant 536-31. As already demonstrated for the 536-21 strains {lnfect. Immun. 42: 57-63) the 018-hly determinant but not the plasmid-encoded hly determinant of pHiy 1 52 transformed into 536-31 contribute to lethality in a mouse peritonitis modal. Similar results were obtained with both Hlyhost strains and their Hly+ transformants in a chicken embryo test and in a mouse nephropathogenicity assay in which the renal bacterial counts were measured 1 5 min to 8 hours after i.v. infection. S-fimbriae and serum resistance had only a marginal influence in these three in vivo systems. ln centrast all three factors, S-fimbriae, serum resistance and hemolysin, were necessary for full virulence in a respiratory mouse infection assay. ln a subcutaneously-induced sepsis model in the mouse restoration of S-fimbriae and serum resistance and separately chromosomally-encoded hemolysis increased virulence to a Ievel comparable to that of the parental 536 strain. KW - Infektionsbiologie KW - E. coli hemolysin KW - S-fimbriae KW - serum resistance KW - E. coli virulence KW - animal models KW - gene cloning Y1 - 1986 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-59423 ER - TY - JOUR A1 - Hof, H. A1 - Emmerling, P. A1 - Hacker, Jörg A1 - Hughes, C. T1 - The role of macrophages in primary and secondary infection of mice with Salmonella typhimurium N2 - Elimination of macrophages with high-molecular dextran sulphate (OS) markedly impairs resistance of mice to primary infection with smooth, virulent strains of Salmonella typhimurium, whereas stimulation of this system by killed Bordetella pertussis organisms increases resistance. In infection with rough, avirulent strains of S. iyphimurium the elimination of macro phages was not followed by an essential loss of resistance, and it appears that other non-specific defence mechanisms, for example the complement system, may have compensated for the lack of macrophages. Macrophages, therefore, play an important role in defence during primary infection with virulent strains. In immunity to challenge infection with S. typhimurium, macrophages play an even more significant role. Treatment with OS completely removes immunity, and both humoral and cell-mediated immune mechanisms seem to require the participation of macrophages. KW - Macrophage KW - Salmonella typhimurium KW - Dextran sulphate KW - Mouse KW - 0 antigen KW - Bordeiella pertussis Y1 - 1982 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-40248 ER - TY - JOUR A1 - Hacker, Jörg A1 - Hof, H. A1 - Hughes, C. A1 - Goebel, W. T1 - Salmonella typhimurium strains carrying hemolysin plasmids and cloned hemolysin. genes from Escherichia coli N2 - Like all other Salmonella typhimurium strains examined, the smooth variants SF1397 (L T2) and 1366 and also their semi-rough and rough derivatives are non-haemolytic. Nevertheless, two haemolysin (Hly) plasmids of E. coli belonging to the inc groups incFllI,lv (pSU316) and incIz (pHly152) were able to be introduced into these strains by conjugation and stably maintained. A considerable percentage of the Hly+ transconjugants obtained had lost parts of their O-side chains, a result of selection for the better recipient capability of « semi-rough» variants rather than the direct influence of the Hly+ plasmids themselves. In contrast to the incF1lI1V plasmid pSU316, which exhibited higher conjugation rates with rough recipients, the incIz plasmid pHly152 was accepted best by smooth strains. Transformation with cloned E. coli haemolysin (hly) determinant was inefficient ( <10-8) for smooth strains, but 102-103 times higher for rough recipients, and was increased by the use of Salmonella-modified DNA. The transform ants and transconjugants were relatively stable and showed the same haemolytic activity as the E. coli donor strains. The virulence of the Hly+ smooth, semi-rough and rough S. typhimurium strains was tested in two mouse models, and neither the mortality rate nor the ability to multiply within the mouse spleen was influenced by the hly determinants. KW - Salmonella typhimurium KW - Plasmid KW - Haemolysin KW - Escherichia coli KW - Virulence Y1 - 1985 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-40309 ER - TY - JOUR A1 - Hof, H. A1 - Christen, A. A1 - Hacker, Jörg T1 - Comparative therapeutic activities of Ciprofloxacin, Amoxicillin, Ceftriaxone and Cotrimoxazole in a new model of experimental infection with Escherichia coli N2 - A new mouse model for systemic infection with Escherichia coli is presented. Whereas in other models 107_108 bacteria have to be injected into an animal to induce toxic effects resulting in death within 24 hours, now, only 103_104 bacteria of an appropriate strain are required to produce a genuine infection characterized by an increase in the bacterial load over several days. The quantitative determination of bacterial counts per liver allows a more sensitive measurement than recording death rates. Furthermore, few animals are required for a definite result in contrast to the LDso determination of other models. The salient point regarding this new model is that conditioning of animals has to be achieved by incorporating the inoculum into agar which is injected subcutaneously. The resulting infection is completely dependent on the E. colicondistrain used. Whereas a hemolytic, uropathogenic strain is so virulent that an overwhelming infection develops within 48 hours after the injection of 103 bacterial cells, a non-hemolytic variant of this strain is completely avirulent, being unable to multiply in spite of the potentiating agar. The hemolytic E. coli strain ATCC 25922 is intermediate in virulence. The bacterial counts per liver increase steadily until death occurs five to seven days after the injection of 104 bacteria. This bacterial infection can be therapeutically influenced by daily treatment with various drugs. Ciprofloxacin, ceftriaxone and co-trimoxazole are able to cure the infection, whereas amoxicillin given orally is only moderately active against this ATCC strain, which is relatively resistant to amoxicillin. N2 - Vergleichende therapeutische Aktivitiiten von Ciprof/oxacin, Amoxicillin, Ceftriaxon und Co-trimoxazol in einem neuen Versuchsmodell fur die experimentelle Infektion mit Escherichia coli. Ein neues Mausmodell fur eine systemische Infektion mit Escherichia coli wird vorgestellt. In anderen Infektionsmodellen mussen 107_108 E. coli pro Maus injiziert werden, was zu einer Intoxikation fUhrt, so daB die Tiere innerhalb von 24 Stunden sterben. In diesem neuen Modell wird eine echte Infektion mit nur 103-104 Bakterien gesetzt, und es folgt dann uber mehrere Tage hinweg eine deutliche Vermehrung der Erreger. Diese kann exakt quantitativ durch die Bestimmung der Keimzahlen in der Leber kontrolliert werden, was eine viel empfindlichere Methode darstellt als die Feststellung von Mortalitatsraten. Weiterhin werden dabei weitaus weniger Mause benotigt, urn eine stichhaltige Aussage zu machen, als fUr eine Bestimmung der LDso erforderlich sind. Der entscheidende Punkt dieses neuen Modells ist, daB die Infektion mit den niedrigen Keimzahlen gebahnt werden muB. Diesgeschieht dadurch, daB das Inokulum in verflussigtem Agar suspendiert wird, bevor es subkutan injiziert wird. Der Infektionsverlauf ist wesentlich abhiingig von der Natur des verwendeten E. coli-Stammes. Wahrend z. B. ein hamolytischer, uropathogener Stamm so virulent ist, daB die Tiere einer fulminanten Infektion nach Injektion von nur 103 Keimen erliegen, ist eine nicht-hamolytische Mutante dieses Stammes vollig avirulent und kann sich selbst trotz der Beigabe von Agar nicht vermehren. Der hamolytische Stamm E. coli A TCC 25922 ist bezuglich seiner Virulenz intermediar, d. h. nach Injektion von 104 Bakterien nimmt die Keimzahl pro Leber standig zu und die Tiere sterben nach funf bis sieben Tagen an dieser Infektion. Gerade dieser Infektionsverlauf kann durch tagliche Verabreichung von Chemotherapeutika beeinfluBt weT-den. Ciprofloxacin, Ceftriaxon und Co-trimoxazol sind in der Lage, eine Ausheilung zu erzielen. Amoxicillin hat nach oraler Gabe nur eine maBige Wirkung aut die Infektion mit diesem ATCC-Stamm, der auch gegen Amoxicillin relativ resistent ist. Y1 - 1986 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-40313 ER - TY - JOUR A1 - Wirbelauer, J. A1 - Hof, H. A1 - Hacker, Jörg T1 - Die Wirkung von Desacetylcefotaxin, einem Metaboliten von Cefotaxim, in vitro und auf die experimentelle Infektion mit Escherichia coli T1 - Activity of Desacetylcefotaxime, a Metabolite of Cefotaxime, In Vitro and in a Model of Experimental Infection with Escherichia coli N2 - Die MHK-Werte von Desacetylcefotaxim gegen verschiedene, z. T. ampicillinresistente Stämme von Escherichia coH, die mit Hilfe einer Agardilutionsmethode erhoben wurden, waren höher als die von Cefotaxim und Ceftriaxon, jedoch niedriger als die von Cefoxitin. In einem Modell der systemischen Infektion der Maus mit einem plasmidtragenden, betalactamaseproduzierenden Stamm von E. coli führte die Therapie mit Desacetylcefotaxim zu einer starken Reduktion der Keime pro Leber. Im Vergleich zur Therapie mit Cefotaxim trat die protektive Wirkung aber verlangsamt ein. Desacetylcefotaxim ist also kein unnützes Abbauprodukt von Cefotaxim. N2 - The MIC values of desacetylcefotaxime, as determined by an agar dilution method, for several strains of Escherichia coli largely resistant to ampicillin were considerably higher than those of cefotaxime or ceftriaxone respectively. The values were, however, definitely lower than those of cefoxitin. In a mouse model of a systemic infection with a plasmid-bearing, j3-lactamase producing strain of E. coli the therapeutic potency of ampicillin, cefotaxime and desacetylcefotaxime was determined by counting the bacterial numbers per liver at days 1,3 and 7 after subcutaneous infection with about 103 viable bacteria. Desacety1cefotaxime was able to redure thc bacterial load considerably, though with a delay in comparison to cefotaxime. Y1 - 1988 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-40348 ER -